{
    "eid": "2-s2.0-85138742175",
    "title": "Nucleoside-modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergens",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [],
    "authors": [
        "Sirikarn Jitthamstaporn",
        "Rueangsit Inthong",
        "Dittaya Audomsun",
        "Supapich Chanasit",
        "Chanatip Thanasarnthungcharoen",
        "Paulo J.C. Lin",
        "Drew Weissman",
        "Norbert Pardi",
        "Alain Jacquet"
    ],
    "citedby-count": 0,
    "ref-count": 7,
    "ref-list": [
        "mRNA vaccines for infectious diseases: principles, delivery and clinical translation",
        "Immunological responses and biomarkers for allergen-specific immunotherapy against inhaled allergens",
        "Antigenic determinants of Der p 1: specificity and cross-reactivity associated with IgE antibody recognition",
        "Conformational IgE epitope mapping of Der p 2 and the evaluations of two candidate hypoallergens for immunotherapy",
        "Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy",
        "Murine models of allergic asthma",
        "Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60023009",
            "affilname": "Penn Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023009",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60003711",
            "affilname": "University of Pennsylvania Perelman School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003711",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Vancouver",
            "@id": "126290746",
            "affilname": "Acuitas Therapeutics",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126290746",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "Center of Excellence in Vaccine Research and Development, Faculty of Medicine, Chulalongkorn University",
        "Chulalongkorn Academic Advancement",
        "Chulalongkorn University",
        "Thailand Science Research and Innovation"
    ]
}